Patenting an invention is essential to protect ideas, with a high technological and innovative impact, that aim to solve a problem by presenting a new and original solution. Patenting a method, an instrument, determines its uniqueness on the market and within the scientific-technological landscape.  

As an innovative startup, Cerebro® currently boasts 3 national and 2 international patents. 


Static cortical transcranial magnetic system, national (n° 102020000028589) and international patent.

Screening device to support clinical diagnoses

in particular the diagnosis of cystic fibrosis, national (n° 102021000002924) and international patent


 non-invasive transcranial brain thermal stimulation system, national patent (n° 102021000008105)